STOCK TITAN

Clarivate Announces Extension of $250 Million Share Repurchase Program

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
buyback
Rhea-AI Summary

Clarivate Plc (NYSE: CLVT) announced an extension of its share repurchase program through January 31, 2022, allowing for up to $250 million in buybacks. As of the announcement, $185 million remains available from the initial authorization, which was set to expire on October 31, 2021. This move aims to enhance shareholder value and demonstrates the company’s commitment to returning capital to investors. The decision reflects positive management confidence in the company's financial position and future growth prospects.

Positive
  • Extension of share repurchase program signals strong management confidence.
  • Remaining buyback capacity of $185 million enhances shareholder value.
Negative
  • None.

LONDON, Oct. 28, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced that its Board of Directors has approved the extension of its share repurchase program through January 31, 2022. The current share repurchase program authorized the Company to purchase up to $250 million of its ordinary shares through open-market purchases, of which $185 million remains available, and was previously set to expire October 31, 2021.

Forward-Looking Statements

This communication contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These statements, which express management's current views concerning future business, events, trends, contingencies, financial performance, or financial condition, appear at various places in this communication and may use words like "aim," "anticipate," "assume," "believe," "continue," "could," "estimate," "expect," "forecast," "future," "goal," "intend," "likely," "may," "might," "plan," "potential," "predict," "project," "see," "seek," "should," "strategy," "strive," "target," "will," and "would" and similar expressions, and variations or negatives of these words. Examples of forward-looking statements include, among others, statements we make regarding: guidance outlook and predictions relating to expected operating results, such as revenue growth and earnings; our expectations around our ability to consummate our pending acquisition of ProQuest, which is subject to customary closing conditions including receipt of approval under the Hart-Scott-Rodino Antitrust Improvements Act of 1976; strategic actions such as acquisitions, joint ventures, and dispositions, including the anticipated benefits therefrom, and our success in integrating acquired businesses; anticipated levels of capital expenditures in future periods; our ability to successfully realize cost savings initiatives and transition services expenses; our belief that we have sufficiently liquidity to fund our ongoing business operations; expectations of the effect on our financial condition of claims, litigation, environmental costs, the COVID-19 pandemic and governmental responses thereto, contingent liabilities, and governmental and regulatory investigations and proceedings; and our strategy for customer retention, growth, product development, market position, financial results, and reserves. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on management's current beliefs, expectations, and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. Because forward-looking statements relate to the future, they are difficult to predict and many of which are outside of our control. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include those factors discussed under the caption "Risk Factors" in our 2020 annual report on Form 10-K/A, along with our other filings with the U.S. Securities and Exchange Commission ("SEC"). However, those factors should not be considered to be a complete statement of all potential risks and uncertainties. Additional risks and uncertainties not known to us or that we currently deem immaterial may also impair our business operations. Forward-looking statements are based only on information currently available to our management and speak only as of the date of this communication. We do not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. Please consult our public filings with the SEC or on our website at www.clarivate.com.  

About Clarivate

Clarivate™ is a global leader in providing solutions to accelerate the lifecycle of innovation. Our bold mission is to help customers solve some of the world's most complex problems by providing actionable information and insights that reduce the time from new ideas to life-changing inventions in the areas of science and intellectual property. We help customers discover, protect and commercialize their inventions using our trusted subscription and technology-based solutions coupled with deep domain expertise.   For more information, please visit clarivate.com.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/clarivate-announces-extension-of-250-million-share-repurchase-program-301410701.html

SOURCE Clarivate Plc

FAQ

What is the total amount authorized for the share repurchase program by Clarivate?

The total amount authorized for the share repurchase program is $250 million.

How much of the share repurchase program remains available as of the latest announcement?

As of the latest announcement, $185 million remains available for repurchase.

Until when has Clarivate extended its share repurchase program?

Clarivate has extended its share repurchase program until January 31, 2022.

What was the expiration date of the previous share repurchase program before the extension?

The previous share repurchase program was set to expire on October 31, 2021.

Clarivate Plc

NYSE:CLVT

CLVT Rankings

CLVT Latest News

CLVT Stock Data

3.20B
389.44M
15.83%
91.83%
4.93%
Information Technology Services
Services-computer Processing & Data Preparation
Link
United States of America
ST. HELIER